The global postmenopausal osteoporosis market is anticipated to grow at a CAGR of around 3.6% during the forecast period (2021-2027). The key factor that drives the market includes the increasing prevalence of osteoporosis disease among the aged population. For instance, according to International Osteoporosis Foundation, United Nations estimates that the “old age” dependency ratio will be increasing dramatically in the 21st century. By 2030, the ratio is forecasted to be 18 seniors per 100 workers which will be further increased to 25.2 per 100 and 37.6 per 100 by 2050. Almost 9 million fragility fractures are taking place annually that includes 1.6 million hip fractures resulting in premature deaths.
To Request a Sample of our Report on Postmenopausal Osteoporosis Market: https://www.omrglobal.com/request-sample/postmenopausal-osteoporosis-market
Rising acquisitions, product approval, product launch collaborations among the major players of the market also propels the growth of the market. For instance, in April 2019, Amgen and UCB announced that the US food and Drug Administration has approved EVENITY for the treatment for postmenopausal osteoporosis in women with a high risk of fractures. EVENITY is one of the first and only bone builder products that have the unique dual effect of increasing bone formation and reducing bone resorption that rapidly reduces the risk of fracture. This approval comes with the post-marketing requirement of the FDA that gives assess of cardiovascular safety of EVENITY in osteoporosis in women with post-menopause.
(Get 15% Discount on Buying this Report)
A full Report of Postmenopausal Osteoporosis Market is Available at: https://www.omrglobal.com/industry-reports/postmenopausal-osteoporosis-market
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Treatment
· By Distribution channel
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Eli Lilly and Co, Pfizer Inc., Proctor & Gamble Co., Amgen Inc., Novartis International AG, Allergan plc.
Global Postmenopausal Osteoporosis Market Report Segment
By Treatment
· Bisphosphonates
· Hormones
· Strontium Ranelate
· Others
By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· E- Commerce Pharmacies
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
